Key facts
- Notable investors include Chinarun Partners, Shanghai Chengpu Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for ShengYa Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for ShengYa Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ShengYa Biotechnology
Manufacturer of in vitro diagnostic reagents and medical testing equipment designed to support clinical diagnostics and public health applications. The company focuses on the research, development, and production of diagnostic reagents and related devices, particularly for maternal and child health and emergency clinical use, enabling healthcare institutions to conduct accurate and efficient laboratory testing while supporting regional biomedical innovation initiatives.
- Sector
- Healthcare
- HQ
- Xiamen, China
- Founded
- 2018
- Ownership
- Privately Held (backing)
ShengYa Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ShengYa Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ShengYa Biotechnology in its N-PORT filings yet. We sweep new filings monthly.